EyeYon Medical
Ophthalmic Products for Vision-threatening Conditions
StartupEyeYon Medical is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2010. Ophthalmic Products for Vision-threatening Conditions. The company has raised a total of $36.14M across 4 funding rounds, currently at the C stage. EyeYon Medical was founded by Nahum Ferera, Arie Marcovich, Ofer Daphna. Key investors include CR-CP Life Science Fund, Triventures, Quark Venture, among 12 total investors. The company has 11-50 employees. Core technologies: Materials & Substances, Implants.
With $36.14M in total funding, EyeYon Medical is a C-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageC
- ProductReleased
- ModelB2B
- Employees11-50
- HQNess Ziona
- DistrictCenter District
- Last Round$25M
- CR-CP Life Science FundLead
- Triventures
- Quark Venture
12 investors total
Nahum FereraCo-founder & CEO
Arie MarcovichCo-founder 
Ofer DaphnaCo-founder & Medical Director
12 articles covered by sources including www.prnewswire.com,
nocamels.com,
www.calcalistech.com,
www.maariv.co.il,
www.globes.co.il.
What does EyeYon Medical do?
EyeYon Medical is a start-up company specializing in developing medical ophthalmic devices for complications resulting from various corneal diseases, including corneal edema. EyeYon Medical has developed exclusive technologies that have proven to have a solution to acute problems in the ophthalmic world. EyeYon Medical's flagship product is an artificial endothelial layer called EndoArt. EndoArt is a synthetic implant attached to the posterior corneal surface to treat chronic corneal edema secondary to endothelial dysfunction. The minimally invasive EndoArt is designed to replace dysfunctional endothelium to cure corneal edema, offering a safe and simple solution that will be available to anyone, anywhere. EyeYon Medical also developed the Hyper CL, an FDA-approved therapeutic contact lens for a variety of corneal conditions that require eye drop treatment.
How much funding has EyeYon Medical raised?
EyeYon Medical has raised $36.14M in total funding across 4 rounds. The company is currently at the C stage. Key investors include CR-CP Life Science Fund, Triventures, Quark Venture.
Who founded EyeYon Medical?
EyeYon Medical was founded in 2010 by Nahum Ferera (Co-founder & CEO), Arie Marcovich (Co-founder ), Ofer Daphna (Co-founder & Medical Director).
What sector is EyeYon Medical in?
EyeYon Medical operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Providers.
Where is EyeYon Medical located?
EyeYon Medical is based in 5 Golda Meir St., Ness Ziona, Israel, Center District.